ANNX+112.14%20.0%
BHVN+11.71%20.0%
DNLI+77.26%20.0%
KYMR+163.22%20.0%
VRTX+3.54%20.0%
As of Jul 10, 2026, 7:14 AM ET
Rare Diseases '25: CNS/Neuro Constituents
| Company | Wgt | Premarket % | 1D % | 10D % | MTD % | YTD % | IranWar % | LibDay % | 1Yr % | Mkt Cap |
|---|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals IncorporatedVRTX | 20.0% | 0.02% | -0.39% | -0.63% | -0.30% | 9.52% | -0.07% | 2.69% | 3.54% | $126.01B |
Kymera Therapeutics, Inc.KYMR | 20.0% | -2.51% | 4.24% | 8.85% | 4.20% | 52.94% | 30.27% | 351.44% | 163.22% | $9.79B |
Denali Therapeutics Inc.DNLI | 20.0% | 0.00% | 1.95% | 5.10% | 4.73% | 64.81% | 28.47% | 98.03% | 77.26% | $4.32B |
Biohaven Ltd.BHVN | 20.0% | -0.03% | 0.90% | 12.31% | 6.54% | 48.72% | 45.75% | -29.10% | 11.71% | $1.78B |
Annexon, Inc.ANNX | 20.0% | -0.93% | -0.34% | 6.64% | 7.03% | 18.33% | 6.07% | 203.06% | 112.14% | $710.4M |
| Theme return | — | -0.69% | 1.27% | 6.45% | 4.01% | 43.74% | 24.19% | 115.83% | 86.34% | — |
| Average | 20.0% | -0.69% | 1.27% | 6.45% | 4.44% | 38.86% | 22.10% | 125.22% | 73.57% | $28.52B |
| Median | 20.0% | -0.03% | 0.90% | 6.64% | 4.73% | 48.72% | 28.47% | 98.03% | 77.26% | $4.32B |
| Std Dev | 0.0% | 0.98% | 1.72% | 4.29% | 2.60% | 21.22% | 16.82% | 139.14% | 60.45% | $48.85B |
| Min | 20.0% | -2.51% | -0.39% | -0.63% | -0.30% | 9.52% | -0.07% | -29.10% | 3.54% | $710.4M |
| Max | 20.0% | 0.02% | 4.24% | 12.31% | 7.03% | 64.81% | 45.75% | 351.44% | 163.22% | $126.01B |
| % Positive Tickers | 20.00% | 60.00% | 80.00% | 80.00% | 100.00% | 80.00% | 80.00% | 100.00% |
About this theme
Rare Diseases '25: CNS/Neuro tracks 5 publicly listed stocks in this theme: ANNX, BHVN, DNLI, KYMR, VRTX. See the constituent table for details.